[1]
“Type 2 Diabetes Mellitus: From Metabolic Dysfunction Syndrome to Precision Prevention and Targeted Therapy”, J. Trop. Pharm. Chem, vol. 10, no. 2, pp. 97–106, Jul. 2026, doi: 10.30872/jtpc.v10i2.439.